Report error Found 5 of ic50 for monomerid = 8732
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus (strain MRSA252))
Glaxosmithkline
Glaxosmithkline
Affinity DataIC50: 50nMpH: 6.5 T: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus (strain MRSA252))
Glaxosmithkline
Glaxosmithkline
Affinity DataIC50: 50nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli (strain K12))
Affinium Pharmaceuticals
Curated by ChEMBL
Affinium Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 139nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli (strain K12))
Affinium Pharmaceuticals
Curated by ChEMBL
Affinium Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Haemophilus influenzae (strain ATCC 51907 / DSM 11...)
Glaxosmithkline
Glaxosmithkline
Affinity DataIC50: 560nMT: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
